Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Autoimmunity 2018

About Conference


Conference Series invites all the participants from all over the world to attend “3rd International Conference on Autoimmunity” during November 26-27 in Dublin, Ireland which includes prompt keynote presentations, Oral talks, Poster presentations, Workshops & Exhibitions.

Our Annual Meeting (Autoimmunity 2018) is both a high quality meeting and a platform for discussion amongst the Autoimmunity interest groups, Immunologist, Research Scholars, Doctors, and Students and provides an informal networking opportunity to form new relationships, and strengthen existing ones. Autoimmunity Conferences provides the time to collaborate with industry peers and discover knowledge and resources that can be used to achieve your personal and organizational goals

Target Audience:

·         Allergists

·         Immunologists

·         Microbiologists

·         Pediatricians

·         Physicians

·         Academicians

·         Health Care professionals

·         Young Research Scholars

·         Students

·         Society & Organizational Members

Sessions to be discussed:

             ·         Cancer Immunology

             ·         Autoimmune Diseases

             ·         Cytokine and Current Research

             ·         Immunometabolism and Autoimmunity

             ·         Inherited Autoimmunity

            ·          Bioinformatics and Autoimmunity

             ·         Pathophysiology and Autoimmunity             

             ·         Autoimmunity and Transplantation

             ·         Genetic Engineering and Therapeutics

             ·         Lupus

             ·         HIV Drugs: Trigger of Autoimmunity

             ·         Molecular Immunology

             ·         Pediatric Autoimmunity

             ·         Ocular Autoimmunity

             ·         Clinical Autoimmunity: Current & Future Research

Benefits of attending the conferences:

  • Medical Conferences expose doctors to new ideas, discoveries, and regulations because medicine and methods are continuously developing
  • By attending other presentations, you will learn from others and improve your own skills and knowledge about on-going research in the relative field
  • Can learn new ideas and approaches to make you more effective and efficient in the field.
  • Chance to meet experts and influencers in the field face-to-face & get hands-on information that is  specific to your research, directly from the experts

    

Scientific Sessions

Scientific Sessions

Conference Series invites all the participants from all over the world to attend “3rd International Conference on Autoimmunity” during November 26-27, 2018 in Dublin, Ireland which includes prompt keynote presentations, Oral talks, Poster presentations, Exhibitions & Workshops

 Our Annual Meeting (Autoimmunity 2018) is both a high quality meeting and a platform for discussion amongst the Allergy interest groups, Immunologist, Research Scholars, Doctors, Students and provides an informal networking opportunity where new friendships or working partnerships are formed and old ones renewed.      

Sessions in the Meeting:

Track-1: Cancer Immunology:

 

Cancer immunology is division of biology which deals with understanding the role of the immune system in the development of cancer and string. The most well notable application in cancer immunology is cancer immunotherapy which taps the immune system as a treatment for cancer. Cancer immunologic surveillance and immunoediting is based on immunity against development of automatic and chemically promote tumors in identification of targets animal systems and for immune recognition of human cancer.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy, September 17-18, 2018 San Diego, USA | 3rd Edition of International Conference on Colorectal cancer, October 11-12, 2018, Zurich-Switzerland | 3rd International Cancer Study & Therapy Conference, May 02 - May 04, 2018, Rome, Italy | 3rd World Congress and Expo on Immunology, October 18-20, 2018 at Amsterdam, Netherlands |10thAnnual Immunology Congress, August 28-29, 2018, Athens, Greece | Cancer Conference 2018, March 19-21, 2018 Valencia, Spain | 30th World Congress on Vaccines and Immunization, October 22-23, 2018 Osaka, Japan.

Track-1I:Autoimmune Diseases:

 

Autoimmunity is the process of Immune Responses of an organism against its own tissues and cells. Any disease that results from such an unusual immune response is termed an autoimmune disease. An Autoimmune disease is a state arising from antibody-mediated immune response abnormalities to a normal body part. There are at least 80 types of autoimmune diseases. Nearly any body part can be involved. Common symptoms include low grade fever and feeling tired. Often symptoms come and go.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018, London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track-III: Cytokine and Current Research:

 

Cytokines are minor secreted proteins released by cells have an exact effect on the connections and interactions amongst cells. Cytokines are locally present in autoimmune lesions where they are produced by inflammation which causes autoimmune attack. Cytokines play prominent roles in inflammation and many other diseases, cytokines are wave holder having the function for passing the wave from one cell to other cells in absolute, manner. The cytokines performance is important in Autoimmune Diseases because of hyperactive waving   by cytokines, which is non-specific and over stimulation of cells.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

8th Global Summit on Neuroscience and Neuroimmunology, August 6-7, 2018, Madrid, Spain; 20th World Congress on Nutrition & Food Sciences, May 14-16, 2018, Tokyo, Japan;11th World Microbiology & Immunology Congress, June 28-29, 2018, Amsterdam, Netherlands;9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track - IV: Immunometabolism and Autoimmunity:

 

Metabolism is necessary for pathogen defense and survival of life. In the Immune Mechanism &Immune Metabolism is essential for Pathogen degradation, by immune cells, time of immune metabolic process high level of signals pass to Immune cells to get stimulate and Immunometabolism process get start by central metabolic pathways and antibacterial immunity has revealed. But if similar antigen is present on host cell it altered immune response and starts demonstration of autoimmune response against host cell and Autoimmune Diseases. Metabolic inflammation acts as metabolic hazard sensors. Cytokines have an essential role in mediating the properties of chronic inflammation on target tissues.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9thMolecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 5thInternational Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany.

 

Track - V: Inherited Autoimmunity:

 

The Autoimmune illnesses are passed from parents to children because of dominancy of allele and gene mutation, epidemiologic and Clinical indication that the data from inherited autoimmune disease are carry forward to next generation because of its self-assemble nature. Multiple number of genes has been connected which cause autoimmune illness in the human beings major histocompatibility complex primarily genes are responsible to cause Autoimmune Diseases. These genes also called the HLA. Sometimes ecological influences resemble with the hereditary susceptibility for generating autoimmune disease. A few such activates have been identified in Autoimmune research, in which including the drugs, specific Mutagenic chemicals, Biological factors, carcinogenic molecules, and family clustering, sometimes the nutritional elements also responsible for Autoimmune Disorder.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

Immune Deficiency and Dysregulation North American Conference, April 26 – 29, 2018, Toronto, Canada; Immunology 2018, May 4-8, 2018, Austin, Texas; 5th European Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29th Annual Conference of the Australasian Society of Clinical Immunology and Allergy, September 4-8, 2018, Canberra, Australia; Annual Congress on Immunology & Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy; September 17-18, 2018 San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rd International Conference on Autoimmunity, November 26-27, 2018 Dublin, Ireland.

Track - VI: Bioinformatics and Autoimmunity:

 

Bioinformatics is the application of technology of computer for management of biological data. Computers are used to store, gather, analyze and integrate genetic and biological information, which can then be applied to gene-based drug development and discovery.  Bioinformatics is an interdisciplinary playing field that develops software tools and methods for understanding biological data. Bioinformatics database mostly used in protein sequences, in Autoimmune Diseases  by using different databases.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018; Moscow, Russia; 5thInternational Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; 12th World Congress on Asthma, COPD & Respiratory Allergy, February 2- 5, 2018, Dubai, United Arab Emirates; 3rd International Conference on Autoimmunity, November 26-27, 2018, Dublin, Ireland.

Track - VII: Pathophysiology and Autoimmunity:

 

Physiological processes where by the useful changes causing from a particular disease called Pathophysiology. A normal immune system involves in the activation of B and T-cells after getting signal from cytokines of microphage and NK cell, and the immune cells undergo differentiation to produce antibodies and  plasma cells to destroy infection causing partials, subsequently in large amounts T-Cell and B-Cell get activated, the normal immune response is assumed to involve B and T cell responses to the same antigen, conformations on the surface of a molecule for B cells and pre-processed peptide fragments of proteins for T cells. Idiotype Cross-Reaction – Idiotypes are antigenic epitopes originate in the antigen-binding portion (Fab) of the immunoglobulin element.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

44th Annual Meeting on Histocompatibility and Immunogenetics, October 1-5, 2018, Baltimore, MD; 32nd European Immunogenetics and  Histocompatibility Conference, 9-12 May, 2018, Venice, Italy; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 5th International Conference on Parasitology, July 12-13, 2018 Paris, France; 10th International Conference on Clinical and Cellular Immunology, August 6-7, 2018 Madrid, Spain; Annual Congress on Immunology & Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy; September 17-18, 2018 San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rd International Conference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rd Antibodies and Bio Therapeutics Congress & B2B, November 08-09, 2017 Las Vegas, Nevada, USA.

Track - VIII: Autoimmunity and Transplantation:

 

More than 10, 0000 patients have received an as treatment for a severe autoimmune disease. Transplantation (HSCT) has been used as a treatment for severe and therapy-refractory for autoimmune diseases. Allogeneic Transplant replaces the auto-reactive host immune system and failure of transplantation and graft-versus-autoimmunity effect seen in patient.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy, September 17-18, 2018 San Diego, USA | 3rd Edition of International Conference on Colorectal cancer, October 11-12, 2018, Zurich-Switzerland | 3rd International Cancer Study & Therapy Conference, May 02 - May 04, 2018, Rome, Italy | 3rd World Congress and Expo on Immunology, October 18-20, 2018 at Amsterdam, Netherlands |10thAnnual Immunology Congress, August 28-29, 2018, Athens, Greece | Cancer Conference 2018, March 19-21, 2018 Valencia, Spain | 30th World Congress on Vaccines and Immunization, October 22-23, 2018 Osaka, Japan.

Track – IX: Genetic Engineering & Therapeutics:

 

To treat Autoimmune Diseases Genetic Engineering & Therapeutics is current research growing wildly in biological research aria, for proper treatment against self-Antigen and new drugs creation, Polyreactive Antibodies; Directed Evolution; Antibody Response; Antibodies in a complex environment; knowledge-based design; and Polyspecificity; is current research going on in research institute. The interface between off-target toxicity; Cellular Immunity in Cancer; Antibody Therapy and Antibodies; Antibody Pharmacokinetics, Cardiometabolic ,Medicine, Optimizing Antibody formats for Immunotherapy,  Polyclonal, Bispecifics, these are top research Therapeutics in genetic engineering.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018, London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track – X: Lupus:

 

Lupus is an autoimmune disease, which means that the immune system omission the body's own tissues as external invaders and charge them and it causes inflammation and a wide variety of symptoms will be visible. Lupus is of three types. Discoid lupus erythematosuscauses a skin rash that doesn't go away; sub-acute cutaneous lupus erythematosus causes skin sores on parts of the body exposed to sun. Drug-induced lupus can be caused by medications and different kind of drugs components. Neonatal lupus a rare type of lupus that affects new-born’s children and foetus.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA;3rd International Conference on Autoimmunity, November 26-27 2018.

Track – XI: HIV Drugs: Trigger of Autoimmunity:

 

Implicit, severe immune sensitive reactions to the anti-HIV drug abacavir materialize through an autoimmune procedure, resulting from the design of drug-induced immunizing agent that are attacked by the body's immune system as all HIV Drugs blocks protein synthesis and enzymes which cause alteration in and enzyme synthesis, autoimmune deformities accrue in HIV Patient and proteins. Many times foreign myalgia’s and arthralgia’s occur in about 5% of patients with HIV, sometimes in association with HIV seroconversion.  Many bone related diseases and HIV-associated arthralgia started progresses towards inflammatory joint disease and disorders because of HIV Treatment.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30, 2018 Valencia, Spain; Hynes Convention Center, March 4–7, 2018, Boston, Massachusetts; 2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS, October 17-18, 2018, Las Vegas, Neveda ,USA; 2nd International Conference & Expo on HIV & AIDS, September 17-18, 2018, Toronto, Canada; International Workshop on HIV & Women, March 2-7, 2018, Boston; 3rd International Conference on Autoimmunity, November 26-27, 2018, Dublin, Ireland

Track-XII: Molecular Immunology:

 

Molecular immunology assign with cell mediated immune responses at lymphoblast like cells and molecular level. Molecular immunology has been spread for better knowledge of the sub-cellular immune responses for defending against and treatment of immune related disorders and immune deficient diseases. Journal of molecular immunology focuses on the in-vivo and in-vitro immunological responses of the host.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

Annual Meeting of the Dutch Society for Immunology, December 13-14, 2017, Netherlands; Immune Deficiency and Dysregulation North American Conference, April 26 – 29, 2018, Toronto, Canada; Immunology 2018, May 4-8, 2018, Austin, Texas; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 5th International Conference on Parasitology, July 12-13, 2018 Paris, France; 10th International Conference on Clinical and Cellular Immunology, August 6-7, 2018 Madrid, Spain; 5th European Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29th Annual Conference of the Australasian Society of Clinical Immunology and Allergy, September 4-8, 2018, Canberra, Australia; Annual Congress on Immunology & Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy; September 17-18, 2018 San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rd International Conference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rd Antibodies and Bio Therapeutics Congress & B2B, November 08-09, 2017 Las Vegas, Nevada, USA.

Track-XIII: Pediatric Autoimmunity:

 

Autoimmune disorders are the most common chronic diseases in the childhood population in current days and when they occur they can be challenging to diagnose and difficult to treat. Pediatric autoimmune neuropsychiatric disorders are more common in children.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9thMolecular Immunology & Immunogenetics Congress, March 08-09, 2018, London, UK; 9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA; 5thInternational Workshop on Asthma and COPD 2018, January 18-20, 2018, Berlin, Germany; ICAAI 2018: 20th International Conference on Allergy, Asthma and Immunology, May 14 - 15, 2018, London, United Kingdom European Academy of Allergy and Clinical Immunology conference, 26 - 30 MAY 2018, Munich, Germany.

Track-XIV: Ocular Autoimmunity:

 

The eye is the illustrative immune-privileged organ in the body. Its antigens were once accept to be solely in the eye, which park behind an expert blood-organ barrier or hidden from blood, and were believed to be undistinguished to the immune cells and immune system. Self-tolerance to ocular elements was therefore admit  to be based not on immune resistance  but on immune shallowness  as a result of their non-self-Identification. In the Autoimmunity the relationship between the eye and the immune system is complex and many effects arise because of in.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018, London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

 

 Track-XV: Clinical Autoimmunity: Current & Future Research:

 

Autoimmune disease contributes substantially to mortality and health care cost each year for the proper treatment because of lacking proper treatment on these diseases. More than 70 million Americans are currently living with an autoimmune disease However, the long term treatment of autoimmune diseases and drugs are showing negative effect on host cells. Immunosuppressive medications that globally dampen immune responses in the patient and making susceptible for other diseases are not the way of medication also These agents are highly effective for many patients and thus remain the current “gold standard” of care because of lacking new research in these topics.

Related Autoimmunity Conferences Autoimmunity Meetings Autoimmunity EventsConference Series:

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy, September 17-18, 2018 San Diego, USA | 3rd Edition of International Conference on Colorectal cancer, October 11-12, 2018, Zurich-Switzerland | 3rd International Cancer Study & Therapy Conference, May 02 - May 04, 2018, Rome, Italy | 3rd World Congress and Expo on Immunology, October 18-20, 2018 at Amsterdam, Netherlands |10thAnnual Immunology Congress, August 28-29, 2018, Athens, Greece | Cancer Conference 2018, March 19-21, 2018 Valencia, Spain | 30th World Congress on Vaccines and Immunization, October 22-23, 2018 Osaka, Japan

Market Analysis

Market Analysis report of Autoimmunity

The global market for autoimmune disease therapeutics is expected to have a robust growth during the forecast period (2016–2026).

Market Analysis of Autoimmune Diseases 

An autoimmune disease is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. The prevalence of autoimmune disease is on rise. The diseases in estimated to be one of the top 10 cause of death in women under the age 65, and is the second highest cause of chronic illness. Also, it is the top cause of morbidity in women in the U.S. There are more than 80 clinically different type of autoimmune diseases identified till date. Some of the common types of autoimmune diseases are Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, and with rising prevalence of autoimmune diseases the demand of drugs used in the treatment for autoimmune disease is also rising.

Autoimmune Disease Therapeutics Market: Drivers and Restraints

Factors contributing to the growth of global autoimmune disease therapeutics market includes, growing prevalence of autoimmune diseases coupled with growing public awareness and increasing automation of laboratories leading to diagnosis of several diagnostic tests simultaneously to generate rapid and error free results. In addition, technological advancements such as the development of novel biomarkers such as Enbrel and Humira, and portable diagnostic point of care equipment are further expected to fuel the market growth in the near future. However, factors such as, inadequate funding in developing countries, high cost involved in the treatment of the disease and non-availability of the treatment in developing countries along with emergence of alternative technologies are the main restraints for the global autoimmune disease therapeutics market.

Autoimmune Disease Therapeutics Market: Segmentation

Global autoimmune disease therapeutics market is segmented by drug class, distribution channeland geography as following:

  • By Drug Class
    • Immunosuppressant’s
    • Anti-Inflammatory Drugs
    • Corticosteroids
    • Non-steroidal anti-inflammatory drugs
    • Biologics
  • By Distribution Channel
  • Hospitals
  • Clinics
  • Drug Stores
  • Independent pharmacies

Autoimmune disease therapeutics Market: Overview

With rising incidence of autoimmune diseases, rapid technological advancements in medical field such as novel biomarkers, rise in healthcare expenditure, development and presence of large untapped opportunities in the emerging markets such as Eastern European, APAC and MEA region are major factors, expected to boost the growth of the global autoimmune disease therapeutics market during the forecast period (2017–2026).

Autoimmune Disease Therapeutics Market: Region-wise Outlook     

The global market for autoimmune disease therapeutics is expected to register a healthy CAGR during the forecast period. Depending on geographic regions, global autoimmune disease therapeutics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan and Middle East & Africa.

North America accounts for the largest market shares in the autoimmune disease therapeutics market owing to growing prevalence of various forms of autoimmune disorders, and presence of government initiatives such as Affordable Care Act and Patient Protection Act.  Increasing healthcare expenditure in the region is also expected to drive the overall autoimmune disease therapeutics market in the near future. According to National Institute of Health estimates in the U.S. the annual expenditure on autoimmune disease therapeutics is estimated to be US$ 100 Bn. Europe is anticipated to be the second largest market during the forecast period owing to increasing government with the focus of improving healthcare infrastructure, growing prevalence of autoimmune diseases, increased penetration of new technologies such as portable diagnostic equipment and novel biomarkers. However, in Eastern Europe presence of large untapped opportunities will fuel the market growth of autoimmune disease therapeutics in the coming years.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Autoimmune disease therapeutics Market: Key Players

Some of the key market players in global autoimmune disease therapeutics market are

·         Abbott Laboratories,

·         Amgen Inc., Genentech Inc., F,

·         Hoffmann-La Roche AG, Merck & Co. Inc,

·         Bayer Schering Pharma AG,

·         Johnson & Johnson Inc,

·         Biogen Idec Inc,

·         GlaxoSmithKline Plc,

·         Squibb Company,

·         Elan Corporation Plc,

·         Eli Lilly and Company,

·         Chugai Pharmaceutical Co. Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Based on the importance, scope and market analysis Conference Series accommodates International symposiums and workshops exclusively on Autoimmunity research. Conference Series Autoimmunity conferences are composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings.

Let us meet @ Autoimmunity-2018 in Dublin, Ireland during November 26-27, 2018

Past Conference Report

Autoimmunity-2017

Autoimmunity 2017: Past Conference Report

Conference series LLC hosted the “2nd International Conference on Autoimmunity” during November 06-07, 2017 Frankfurt, Germany at H4 Hotel Frankfurt Messe with the theme “Exploring Novel Facets in Autoimmunity and Immune systems”. Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Immunologists, Scientists, Researchers, Students and Leaders in Autoimmunity, who made this event successful.

The conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Autoimmune Disease
  • Autoimmune Treatment
  • Cytokine and Current Research
  • Neurodisorders
  • Antibodies: Engineering & Therapeutics
  • Inherited Autoimmunity
  • Clinical Autoimmunity: Current & Future Research
  • HIV Drugs: Trigger of Autoimmunity
  • Malignancy: The great Autoimmune Diseases
  • Immunotherapy Research
  • Lupus
  • Immune System and Autoimmunity
  • Molecular Immunology
  • Pediatric Autoimmunity
  • Immunometabolism and Autoimmunity
  • Ocular Autoimmunity

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

·                    Aaron Lerner, AESKU.KIPP Institute, Wendelsheim, Germany

·                    Tse-Hua Tan, National Health Research Institutes, Taiwan

·                    Gislane Lelis Vilela de Oliveira, Microbiome Study Group, School of Health Sciences Dr. Paulo Prata, Brazil

·                    Huai-Chia Chuang, National Health Research Institutes, Taiwan

All the above mentioned Honourable Guests and Keynote speakers gave their energetic and fruitful contributions. Special thanks to our Moderator Nico Marr, Sidra Medical and Research Centre, Qatar, and Tse-Hua Tan, National Health Research Institutes, Taiwan for his remarkable contribution towards smooth functioning at Autoimmunity 2017.

Conference Sessions Chairs:

·         Aaron Lerner, AESKU.KIPP Institute, Wendelsheim, Germany

·         Gislane Lelis Vilela de Oliveira, Microbiome Study Group, School of Health Sciences Dr. Paulo Prata, Brazil

Conference Series LLC offers is obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Autoimmunity 2017, Conference Series LLC is delighted to announce the next event. Mark your calendars for the upcoming extravaganza,"3rdInternational Conference on Autoimmunity" to be held during November 26-27, 2018 at Dublin, Ireland.

Let us meet again @ Autoimmunity 2018


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 26-27, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Cellular Immunology Immunome Research Journal of Clinical Research & Bioethics

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by